NanoViricides, Inc. (NNVC)

NanoViricides Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 27, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Cap	42	23	23	13	22	53
Market Cap Growth	90.70%	2.84%	68.05%	-38.27%	-59.21%	-21.36%
Enterprise Value	31.19	21.69	17.81	5.3	7.82	33.01
Last Close Price	1.85	1.40	1.72	1.15	1.88	4.64
PB Ratio	3.57	3.09	1.97	0.90	0.94	1.79
P/TBV Ratio	3.78	2.82	1.78	0.90	0.94	1.69
Debt / Equity Ratio	-	0	0	0	0.00	0.00
Net Debt / Equity Ratio	-0.35	-0.21	-0.42	-0.55	-0.60	-0.68
Net Debt / EBITDA Ratio	0.42	0.18	0.62	0.99	1.89	2.55
Net Debt / FCF Ratio	0.44	0.18	0.74	1.40	2.25	2.42
Quick Ratio	3.02	1.19	3.53	15.25	34.07	58.43
Current Ratio	3.17	1.28	3.66	15.81	34.92	59.30
Return on Equity (ROE)	-80.01%	-99.75%	-63.00%	-45.27%	-30.60%	-34.15%
Return on Assets (ROA)	-72.72%	-88.62%	-57.30%	-44.28%	-30.19%	-32.28%
Return on Invested Capital (ROIC)	-137.85%	-151.94%	-114.45%	-103.24%	-87.24%	-93.60%
Return on Capital Employed (ROCE)	-80.85%	-101.06%	-61.20%	-45.34%	-30.62%	-33.85%
Buyback Yield / Dilution	-32.11%	-27.34%	-2.11%	-0.79%	-5.81%	-94.08%
Total Shareholder Return	-32.11%	-27.34%	-2.11%	-0.79%	-5.81%	-94.08%

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q